These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 2268866)
21. A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections. Cooper TJ; Ladusans E; Williams PE; Polychronopoulos V; Gaya H; Rudd RM J Antimicrob Chemother; 1985 Sep; 16(3):373-8. PubMed ID: 4055545 [TBL] [Abstract][Full Text] [Related]
22. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group. Siegert R; Gehanno P; Nikolaidis P; Bagger-Sjöbäck D; Ibanez JM; Hampel B; Sommerauer B Respir Med; 2000 Apr; 94(4):337-44. PubMed ID: 10845431 [TBL] [Abstract][Full Text] [Related]
23. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. Chodosh S; McCarty J; Farkas S; Drehobl M; Tosiello R; Shan M; Aneiro L; Kowalsky S Clin Infect Dis; 1998 Oct; 27(4):722-9. PubMed ID: 9798024 [TBL] [Abstract][Full Text] [Related]
24. Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis. Vogel F; Droszcz W; Vondra V; Reisenberg K; Marr C; Staley H J Antimicrob Chemother; 1997 Dec; 40(6):863-71. PubMed ID: 9462439 [TBL] [Abstract][Full Text] [Related]
25. [Parenteral cephalosporins for the treatment of lower respiratory tract infections]. Vogel F Infection; 1993; 21 Suppl 1():S28-34. PubMed ID: 8314290 [TBL] [Abstract][Full Text] [Related]
26. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462 [TBL] [Abstract][Full Text] [Related]
27. Cefuroxime axetil in the treatment of sinusitis. A review. Pakes GE; Graham JA; Rauch AM; Collins JJ Arch Fam Med; 1994 Feb; 3(2):165-75. PubMed ID: 7994439 [TBL] [Abstract][Full Text] [Related]
28. Cefuroxime axetil. Dellamonica P Int J Antimicrob Agents; 1994 Mar; 4(1):23-36. PubMed ID: 18611587 [TBL] [Abstract][Full Text] [Related]
29. Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis. Zervos MJ; Heyder AM; Leroy B J Int Med Res; 2003; 31(3):157-69. PubMed ID: 12870368 [TBL] [Abstract][Full Text] [Related]
30. Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis. Klein GL; Whalen E; Echols RM; Heyd A J Otolaryngol; 1998 Feb; 27(1):10-6. PubMed ID: 9511113 [TBL] [Abstract][Full Text] [Related]
31. Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil. Alvarez-Sala JL; Kardos P; Martínez-Beltrán J; Coronel P; Aguilar L Antimicrob Agents Chemother; 2006 May; 50(5):1762-7. PubMed ID: 16641447 [TBL] [Abstract][Full Text] [Related]
32. [Role of cefuroxime-axetil in the treatment of respiratory tract infections. Bacteriological and pharmacological data]. Bergogne-Berezin E; Vallée E; Muller-Serieys C Therapie; 1991; 46(4):333-7. PubMed ID: 1948811 [TBL] [Abstract][Full Text] [Related]
33. A comparison of the safety and efficacy of cefuroxime axetil and cefaclor in outpatient management of community-acquired lower respiratory tract infections. Nolen TM; Hutchison J; Phillips HL J Chemother; 1989 Jul; 1(4 Suppl):768-9. PubMed ID: 16312631 [No Abstract] [Full Text] [Related]
34. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Vergis EN; Indorf A; File TM; Phillips J; Bates J; Tan J; Sarosi GA; Grayston JT; Summersgill J; YU VL Arch Intern Med; 2000 May; 160(9):1294-300. PubMed ID: 10809032 [TBL] [Abstract][Full Text] [Related]
35. Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice. Rossi R; Castellani P; Younes G; Della Bruna C J Antimicrob Chemother; 1989 Mar; 23 Suppl C():149-55. PubMed ID: 2732136 [TBL] [Abstract][Full Text] [Related]
36. Cefuroxime efficacy in pneumonia: sequential short-course i.v./oral suspension therapy. Shalit I; Dagan R; Engelhard D; Ephros M; Cuningham K Isr J Med Sci; 1994 Sep; 30(9):684-9. PubMed ID: 8088980 [TBL] [Abstract][Full Text] [Related]
37. Oral ofloxacin therapy for lower respiratory tract infection. Gentry LO; Lipsky B; Farber MO; Tucker B; Rodriguez-Gomez G South Med J; 1992 Jan; 85(1):14-8. PubMed ID: 1734527 [TBL] [Abstract][Full Text] [Related]
38. Experience with cefuroxime in 190 patients with severe respiratory infections. Pines A; Raafat H; Kennedy MR; Mullinger BM Chemotherapy; 1980; 26(3):212-7. PubMed ID: 7363715 [TBL] [Abstract][Full Text] [Related]
39. [Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract]. Bogdanov MB; Chernen'kaia TV Antibiot Khimioter; 2000; 45(10):15-8. PubMed ID: 11212394 [TBL] [Abstract][Full Text] [Related]